Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer Management and …, 2019 - Taylor & Francis
Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …
被引用次数：29 相关文章

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer Management and …, 2019 - go.gale.com
Endometrial cancer (EC) is the most common gynecologic malignancy in developed
countries.(1) Although EC is typically thought to be a cancer affecting postmenopausal …
[HTML] nih.gov

[HTML][HTML] Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer Management and …, 2019 - ncbi.nlm.nih.gov
Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer Management and …, 2019 - europepmc.org
Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …

[引用][C] Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai, Z Zhang - Cancer Management and …, 2019 - cir.nii.ac.jp
<p>Weight control is vital for patients with early-stage endometrial cancer or complex atypical
hyperplasia who have received progestin therapy to spare fertility: a systematic review and …

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer Management and …, 2019 - dovepress.com
Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a …

M Li, T Guo, R Cui, Y Feng, H Bai… - Cancer management …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …